News Novo aims for GLP-1 sales growth in China Novo expects Victoza and semaglutide to gain momentum.
News Novo highlights key 'hypo' data from Tresiba at EASD Novo hopes data will justify higher price compared with rival.
News AZ talks up Bydureon data, GLP-1 and glucagon combo AstraZeneca is hoping new data showing its Bydureon diabetes drug cuts overall death risk could stave off competition from Novo Nordisk's potential next generation GLP-1 drug.
News Fitbit and Dexcom to bring diabetes data to Ionic smartwatch Dexcom G5 Mobile data will be displayed on Fitbit's Ionic smartwatch.
News FDA clears finger-prick free insulin pump-CGM combo Device combination capable of recommending treatment decisions without finger-pricking.
Oncology CAR-T therapies: Faster, better, cheaper In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
